Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Jäger

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Current Medicinal Chemistry|April 23, 2002
Metabolism of the novel IMP dehydrogenase inhibitor benzamide ribosideWalter Jäger, Alexandra Salamon, Thomas Szekeres
Annual Review of Pharmacology and Toxicology|September 21, 2016
Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal SupplementsBruno Stieger, Zainab M Mahdi, Walter Jäger
Wiener Medizinische Wochenschrift (1946)|August 11, 2005
[Examination of stability and compatibility of flucloxacillin (Floxapen) and ceftazidime (Fortum) in two infusion media: relevance for the clinical praxis]Florian Thalhammer, Alexandra Maier-Salamon, Walter Jäger
The Journal of Antimicrobial Chemotherapy|November 18, 2024
Insights into interspecies protein binding variability using clindamycin as an exampleHifza Ahmed, Michaela Böhmdorfer, Walter Jäger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 10, 2019
Resveratrol and other dietary polyphenols are inhibitors of estrogen metabolism in human breast cancer cellsStefan Poschner, Alexandra Maier-Salamon, Theresia Thalhammer, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 2, 2017
Simultaneous quantification of estrogens, their precursors and conjugated metabolites in human breast cancer cells by LC-HRMS without derivatizationStefan Poschner, Martin Zehl, Alexandra Maier-Salamon, et al.
Molecular Pharmaceutics|October 16, 2015
Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification ModelsEleni Kotsampasakou, Stefan Brenner, Walter Jäger, et al.
Pharmaceutical Research|March 17, 2010
Resveratrol and resveratrol analogues--structure-activity relationshipThomas Szekeres, Monika Fritzer-Szekeres, Philipp Saiko, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferasesMichaela Miksits, Michael Sulyok, Rainer Schuhmacher, et al.
Natural Product Communications|April 30, 2015
Cytotoxic active constituents of essential oils of Curcuma longa and Curcuma zanthorrhizaErich Schmidt, Boris Ryabchenko, Juergen Wanner, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Current Medicinal Chemistry|April 23, 2002
Metabolism of the novel IMP dehydrogenase inhibitor benzamide ribosideWalter Jäger, Alexandra Salamon, Thomas Szekeres
Annual Review of Pharmacology and Toxicology|September 21, 2016
Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal SupplementsBruno Stieger, Zainab M Mahdi, Walter Jäger
Wiener Medizinische Wochenschrift (1946)|August 11, 2005
[Examination of stability and compatibility of flucloxacillin (Floxapen) and ceftazidime (Fortum) in two infusion media: relevance for the clinical praxis]Florian Thalhammer, Alexandra Maier-Salamon, Walter Jäger
The Journal of Antimicrobial Chemotherapy|November 18, 2024
Insights into interspecies protein binding variability using clindamycin as an exampleHifza Ahmed, Michaela Böhmdorfer, Walter Jäger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 10, 2019
Resveratrol and other dietary polyphenols are inhibitors of estrogen metabolism in human breast cancer cellsStefan Poschner, Alexandra Maier-Salamon, Theresia Thalhammer, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 2, 2017
Simultaneous quantification of estrogens, their precursors and conjugated metabolites in human breast cancer cells by LC-HRMS without derivatizationStefan Poschner, Martin Zehl, Alexandra Maier-Salamon, et al.
Molecular Pharmaceutics|October 16, 2015
Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification ModelsEleni Kotsampasakou, Stefan Brenner, Walter Jäger, et al.
Pharmaceutical Research|March 17, 2010
Resveratrol and resveratrol analogues--structure-activity relationshipThomas Szekeres, Monika Fritzer-Szekeres, Philipp Saiko, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferasesMichaela Miksits, Michael Sulyok, Rainer Schuhmacher, et al.
Natural Product Communications|April 30, 2015
Cytotoxic active constituents of essential oils of Curcuma longa and Curcuma zanthorrhizaErich Schmidt, Boris Ryabchenko, Juergen Wanner, et al.
Pageof 14